Fig. 5From: Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in ChinaEstimates of net social value under three targeted approaches to lipid and blood pressure management. Notes: The three targeted approaches to lipid and blood pressure management include (i) treating all those with hyperlipidemia with a measure of LDL-C >130 mg/dL, and/or hypertension with SBP > 140 mmHg who had at least one other CVD risk factor; (ii) treating all with a measure of LDL-C >130 mg/dL (and/or SBP > 140 mmHg) and ages 55 years or older; and (iii) treating all with a measure of LDL-C >130 mg/dL (and/or SBP > 140 mmHg) and ages 65 years or older. Data are based on authors’ calculations. The assumed value of a life year in China is estimated at $13,408 (twice the GDP per capita in 2015). Approximately 23 % of the above estimates accrued between 2016 and 2020 and 55 % accrued between 2016 and 2025Back to article page